Cardiac disease in the non-cardiac surgical population: effect on survival

Corina Naughton1, Naomh Reilly, R Feneck

  • 1Trinity Centre for Health Science, St James Hospital, Dublin, Ireland, UK.

British Journal of Nursing (Mark Allen Publishing)
|August 24, 2005
PubMed

Insights

Patients with cardiac risk factors undergoing non-cardiac surgery face a significant risk of death within one year. Angina nearly doubles this risk, highlighting the need for careful pre-assessment and follow-up care.

Area of Science:

  • Cardiology
  • Surgery
  • Public Health

Background:

  • Increasing prevalence of ischemic heart disease, diabetes, and hypertension.
  • Aging population impacting surgical patient demographics.
  • Limited data on mortality for UK patients with cardiac risk factors undergoing non-cardiac surgery.

Purpose of the Study:

  • Determine mortality rates at 1, 6, and 24 months for patients with cardiac risk factors undergoing elective non-cardiac surgery.
  • Identify independent risk factors for 1-year mortality in this cohort.

Main Methods:

  • Retrospective study of 1622 patients undergoing elective non-cardiac surgery.
  • Collection of demographic, pre-, peri-, and postoperative variables.
  • Follow-up via National Office of Statistics and death certificates; analysis using multiple regression.

Main Results:

  • 1-year survival rate was 89%.
  • Most cardiac deaths occurred within 6 months post-surgery.
  • Independent risk factors for 1-year mortality included advanced age, preoperative angina (OR=1.59), surgery type, blood transfusion, and prolonged hospital stay.

Conclusions:

  • A notable proportion of non-cardiac surgical patients with cardiac risk factors are susceptible to cardiac death within a year.
  • Preoperative angina significantly increases mortality risk.
  • Effective pre-assessment, critical care, and primary care follow-up are crucial for managing these patients and reducing mortality.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...